LU83649A1 - Quinolones,leurs procedes de preparation et composition therapeutiques les contenant - Google Patents

Quinolones,leurs procedes de preparation et composition therapeutiques les contenant Download PDF

Info

Publication number
LU83649A1
LU83649A1 LU83649A LU83649A LU83649A1 LU 83649 A1 LU83649 A1 LU 83649A1 LU 83649 A LU83649 A LU 83649A LU 83649 A LU83649 A LU 83649A LU 83649 A1 LU83649 A1 LU 83649A1
Authority
LU
Luxembourg
Prior art keywords
quinolone
methyl
compound
general formula
melting point
Prior art date
Application number
LU83649A
Other languages
English (en)
French (fr)
Inventor
Roy Victor Davies
Original Assignee
Boots Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co Ltd filed Critical Boots Co Ltd
Publication of LU83649A1 publication Critical patent/LU83649A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/233—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/24—Oxygen atoms attached in position 8
    • C07D215/26—Alcohols; Ethers thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Quinoline Compounds (AREA)
LU83649A 1980-09-26 1981-09-24 Quinolones,leurs procedes de preparation et composition therapeutiques les contenant LU83649A1 (fr)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
GB8031162 1980-09-26
GB8031162 1980-09-26
GB8031106 1980-09-26
GB8031106 1980-09-26
GB8119062 1981-06-19
GB8118879 1981-06-19
GB8118879 1981-06-19
GB8119062 1981-06-19

Publications (1)

Publication Number Publication Date
LU83649A1 true LU83649A1 (fr) 1983-02-22

Family

ID=27449208

Family Applications (1)

Application Number Title Priority Date Filing Date
LU83649A LU83649A1 (fr) 1980-09-26 1981-09-24 Quinolones,leurs procedes de preparation et composition therapeutiques les contenant

Country Status (25)

Country Link
US (2) US4442109A (de)
AT (1) AT379388B (de)
AU (1) AU549078B2 (de)
BG (2) BG36495A3 (de)
CA (1) CA1146943A (de)
CH (1) CH650254A5 (de)
DD (1) DD201890A5 (de)
DE (1) DE3138121A1 (de)
DK (1) DK152674C (de)
ES (2) ES505786A0 (de)
FI (1) FI812997L (de)
FR (1) FR2491064A1 (de)
GR (1) GR75797B (de)
IE (1) IE51542B1 (de)
IL (1) IL63845A (de)
IT (1) IT1189449B (de)
LU (1) LU83649A1 (de)
NL (1) NL8104394A (de)
NO (1) NO154052C (de)
NZ (1) NZ198414A (de)
PH (1) PH18605A (de)
PT (1) PT73666B (de)
RO (2) RO82014A (de)
SE (1) SE457533B (de)
YU (2) YU230181A (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT79031B (en) * 1983-08-20 1986-08-22 Boots Co Plc Therapeutic agents
DE3578374D1 (de) * 1984-01-13 1990-08-02 Boots Co Ltd Verwendung von chinolonen fuer die herstellung eines arzneimittels zur behandlung von herzerkrankungen.
DE3576686D1 (de) * 1984-08-15 1990-04-26 Boots Co Ltd Chinolinone, verfahren zu ihrer herstellung und die sie enthaltenden pharmazeutischen praeparate.
GB8515207D0 (en) * 1985-06-15 1985-07-17 Boots Co Plc Therapeutic agents
GB8515209D0 (en) * 1985-06-15 1985-07-17 Boots Co Plc Therapeutic agents
GB8627698D0 (en) * 1986-11-20 1986-12-17 Boots Co Plc Therapeutic agents
GB8726950D0 (en) * 1987-11-18 1987-12-23 Boots Co Plc Chemical process
GB8804016D0 (en) * 1988-02-22 1988-03-23 Boots Co Plc Therapeutic agents

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3121725A (en) * 1960-07-18 1964-02-18 Phillips Petroleum Co N-heterocyclic sulfides, sulfoxides, sulfones, and n-oxides of said sulfoxides and sulfones
US3801644A (en) * 1971-08-25 1974-04-02 Warner Lambert Co Substituted-o-hydroxy-omega-(methylsulfinyl)acetophenones and process for producing same
US3772301A (en) * 1971-11-22 1973-11-13 Warner Lambert Co (4-substituted)4-(methylsulfinyl)methylcarbostyrils
GB2038825B (en) * 1978-12-16 1983-02-09 Wyeth John & Brother Ltd Heterocyclic compounds substituted by heterocyclyl-alkyl-thio groups
US4343805A (en) * 1978-12-16 1982-08-10 John Wyeth & Brother Limited Heterocyclic compounds
ZA801575B (en) * 1979-03-27 1981-03-25 Boots Co Ltd Therapeutic agents
NZ193167A (en) * 1979-03-27 1984-08-24 Boots Co Plc Quinoline derivatives and pharmaceutical compositions
US4302360A (en) * 1980-01-11 1981-11-24 Agency Of Industrial Science & Technology Catalyst for catalytic combustion of hydrogen

Also Published As

Publication number Publication date
FR2491064B1 (de) 1984-03-16
AU7552481A (en) 1982-04-01
IE812033L (en) 1982-03-02
YU230181A (en) 1983-12-31
RO82014B (ro) 1983-05-30
AT379388B (de) 1985-12-27
DD201890A5 (de) 1983-08-17
US4447435A (en) 1984-05-08
BG36344A3 (bg) 1984-10-15
DE3138121A1 (de) 1982-04-15
SE457533B (sv) 1989-01-09
FI812997A7 (fi) 1982-03-27
CH650254A5 (fr) 1985-07-15
NL8104394A (nl) 1982-04-16
ES514411A0 (es) 1983-05-01
NO154052B (no) 1986-04-01
YU144683A (en) 1983-12-31
CA1146943A (en) 1983-05-24
IL63845A (en) 1985-02-28
IT8149370A1 (it) 1983-03-25
BG36495A3 (bg) 1984-11-15
RO82014A (ro) 1983-06-01
SE8105689L (sv) 1982-03-27
PH18605A (en) 1985-08-21
DK152674B (da) 1988-04-11
IT8149370A0 (it) 1981-09-25
DK424781A (da) 1982-03-27
NZ198414A (en) 1983-11-18
FR2491064A1 (fr) 1982-04-02
NO154052C (no) 1986-07-16
IT1189449B (it) 1988-02-04
ATA412181A (de) 1985-05-15
DK152674C (da) 1988-08-22
AU549078B2 (en) 1986-01-16
RO85318B (ro) 1984-10-30
FI812997L (fi) 1982-03-27
NO813263L (no) 1982-03-29
IL63845A0 (en) 1981-12-31
ES8306111A1 (es) 1983-05-01
RO85318A (ro) 1984-09-29
IE51542B1 (en) 1987-01-07
GR75797B (de) 1984-08-02
ES8302662A1 (es) 1982-12-01
US4442109A (en) 1984-04-10
PT73666B (en) 1982-11-22
ES505786A0 (es) 1982-12-01
PT73666A (en) 1981-10-01

Similar Documents

Publication Publication Date Title
EP0399856B1 (de) Pteridin-4 (3H)-onen, Verfahren zu ihrer Herstellung und sie enthaltende Medikamente
EP0283390B1 (de) Thiazolderivate mit Aktivität auf das cholinergische System, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammenstellungen
LU86406A1 (fr) Imidazoquinoleines antithrombogenes cardiotoniques
CH644366A5 (fr) Quinolones substituees utiles comme agents therapeutiques et procede pour leur preparation.
EP0624575A1 (de) Substituierte Indole und diese enthaltende Arzneimittel
EP0611766A1 (de) Polysubstituierte 2-Amidothiazole-Derivate, Verfahren zu ihrer Herstellung, pharmazeutische Zusammenstellungen die sie enthalten und ihre Anwendung für die Bereitung eines Arzneimittels
CH646967A5 (fr) Composes de pyranone et compositions pharmaceutiques les comprenant.
EP0205362B1 (de) Chinolylglycinamidderivate, Verfahren zu ihrer Herstellung und therapeutische Verwendung als Psychotrope
EP0162776B1 (de) Heterozyklische Derivate, Verfahren zu ihrer Herstellung, die sie enthaltenden Arzneimittel brauchbar als Aldosereduktaseinhibitoren
LU83649A1 (fr) Quinolones,leurs procedes de preparation et composition therapeutiques les contenant
EP0117771B1 (de) Imino-2-pyrrolidine, Verfahren zu ihrer Herstellung und ihre therapeutische Verwendung
EP0231709B1 (de) Phenylnaphthyridine mit einer funktionellen Gruppe in Position 3, Verfahren zu ihrer Herstellung, diese enthaltende Arzneimittel besonders als Anti-Ulcus
EP0115979A1 (de) Derivate von 1H,3H-Pyrrolo(1,2-c)thiazol, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
EP0017578B1 (de) 5-(2-Hydroxy-3-thiopropoxy)-chromon-2-carbonsäuren, ihre Salze und Ester, Verfahren zur Herstellung und Arzneimittel
BE779775A (fr) Derives de l'uree, procede pour les preparer et leurs applications
EP0062580B1 (de) Imidazo(1,2-a)chinolinderivate
RU2069212C1 (ru) Производные имидазола
FR2514003A1 (fr) Nouvelles xanthines a activite pharmacologique, leur procede d'obtention, les compositions pharmaceutiques qui les contiennent et leur utilisation en medecine humaine
BE890477A (fr) Quinolones, leurs procedes de preparation et composition therapeutique les contenant
EP0196943A1 (de) 8-Thiotetrahydrochinoleinderivate und deren Salze
EP0362006A1 (de) Chinolinderivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
GB2085441A (en) Therapeutic agents
EP0168309B1 (de) Isoxazolochinolinonderivate, Verfahren und Zwischenprodukte zu ihrer Herstellung, Verwendung als Arzneimittel und die sie enthaltenden Zubereitungen
EP0412014A1 (de) Benzothiazinderivate, ihre Herstellung und ihre Verwendungen als Arzneimittel oder als Zwischenprodukte zur Synthese von Arzneimitteln
EP0269841B1 (de) 1-Hydroxyalkylxanthine, Verfahren zu ihrer Herstellung und sie enthaltende Medikamente